The Save the Children Immunisation Accelerator, funded by GSK, has awarded two innovation projects for finding unique solutions to help more children receive vaccinations. With an estimated 2.1 million children in Nigeria and almost one million in Ethiopia1 classed as ‘zero dose’, having never received a routine vaccination, the Save the Children Immunisation Accelerator was launched in April 2024, to empower local organisations and fast-track cutting-edge solutions. A call for submissions then invited Ethiopian and Nigerian innovators to submit proposals. Selected from 120 submissions by a panel, including global health…
Read MoreInnovations breaking barriers to children’s immunisation in Nigeria and Ethiopia win major funding from Save the Children
